Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Realistic fear of cervical cancer risk in Japan depending on birth year.
Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa A, Asai-Sato M, Miyagi E, Yamaguchi M, Kudo R, Adachi S, Sekine M, Enomoto T, Horikoshi Y, Takagi T, Shimura K. Yagi A, et al. Among authors: nakae r. Hum Vaccin Immunother. 2017 Jul 3;13(7):1700-1704. doi: 10.1080/21645515.2017.1292190. Epub 2017 Mar 8. Hum Vaccin Immunother. 2017. PMID: 28272968 Free PMC article.
HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine.
Sawada M, Ueda Y, Yagi A, Morimoto A, Nakae R, Kakubari R, Abe H, Egawa-Takata T, Iwamiya T, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T. Sawada M, et al. Among authors: nakae r. Int J Clin Oncol. 2018 Feb;23(1):121-125. doi: 10.1007/s10147-017-1188-9. Epub 2017 Oct 6. Int J Clin Oncol. 2018. PMID: 28986659 Free PMC article.
Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.
Yagi A, Ueda Y, Tanaka Y, Nakae R, Kakubari R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Matsumura N, Yoshino K, Kimura T, Saito J, Ikeda S, Asai-Sato M, Miyagi E, Sekine M, Enomoto T, Hirai K, Horikoshi Y, Takagi T, Shimura K. Yagi A, et al. Among authors: nakae r. Hum Vaccin Immunother. 2018;14(10):2497-2502. doi: 10.1080/21645515.2018.1480240. Epub 2018 Jun 29. Hum Vaccin Immunother. 2018. PMID: 29883254 Free PMC article.
Treatment and repair of uterine scar dehiscence during cesarean section.
Sawada M, Matsuzaki S, Nakae R, Iwamiya T, Kakigano A, Kumasawa K, Ueda Y, Endo M, Kimura T. Sawada M, et al. Among authors: nakae r. Clin Case Rep. 2017 Jan 19;5(2):145-149. doi: 10.1002/ccr3.766. eCollection 2017 Feb. Clin Case Rep. 2017. PMID: 28174640 Free PMC article.
An artificial intelligence-assisted diagnostic system improves the accuracy of image diagnosis of uterine cervical lesions.
Ito Y, Miyoshi A, Ueda Y, Tanaka Y, Nakae R, Morimoto A, Shiomi M, Enomoto T, Sekine M, Sasagawa T, Yoshino K, Harada H, Nakamura T, Murata T, Hiramatsu K, Saito J, Yagi J, Tanaka Y, Kimura T. Ito Y, et al. Among authors: nakae r. Mol Clin Oncol. 2022 Feb;16(2):27. doi: 10.3892/mco.2021.2460. Epub 2021 Dec 8. Mol Clin Oncol. 2022. PMID: 34987798 Free PMC article.
CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
Nakae R, Matsuzaki S, Serada S, Matsuo K, Shiomi M, Sato K, Nagase Y, Matsuzaki S, Nakagawa S, Hiramatsu K, Okazawa A, Kimura T, Egawa-Takata T, Kobayashi E, Ueda Y, Yoshino K, Naka T, Kimura T. Nakae R, et al. Am J Obstet Gynecol. 2021 Feb;224(2):197.e1-197.e23. doi: 10.1016/j.ajog.2020.08.028. Epub 2020 Aug 19. Am J Obstet Gynecol. 2021. PMID: 32822640
Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
Yoshino K, Kamiura S, Yokoi T, Nakae R, Fujita M, Takemura M, Adachi K, Wakimoto A, Nishizaki T, Shiki Y, Tsutsui T, Kanda Y, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Sawada K, Tomimatsu T, Kimura T. Yoshino K, et al. Among authors: nakae r. Cancer Chemother Pharmacol. 2017 Dec;80(6):1239-1247. doi: 10.1007/s00280-017-3468-5. Epub 2017 Oct 28. Cancer Chemother Pharmacol. 2017. PMID: 29080971 Clinical Trial.
CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer.
Shiomi M, Matsuzaki S, Serada S, Matsuo K, Mizuta-Odani C, Jitsumori M, Nakae R, Matsuzaki S, Nakagawa S, Hiramatsu K, Miyoshi A, Kobayashi E, Kimura T, Ueda Y, Yoshino K, Naka T, Kimura T. Shiomi M, et al. Among authors: nakae r. Cancer Sci. 2021 Sep;112(9):3655-3668. doi: 10.1111/cas.15027. Epub 2021 Jul 8. Cancer Sci. 2021. PMID: 34117815 Free PMC article.
79 results